Biotechnology Jobs

• Mississauga, Canada
• On-site
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical programme teams, leading medical monitoring and safety oversight for lung and head/neck cancer studies. Interprets clinical and safety data, contributes to protocol development, and engages investigators, regulators and cross-functional matrix teams across Phase I–III development.

• Zug, Switzerland
• Hybrid · 2 days in office
• US$189,750 – US$316,250 pa
• Director

Serves as the physician within an oncology clinical program team, leading medical monitoring and safety oversight for genitourinary cancer studies. Interprets clinical and safety data, contributes to protocol development and regulatory interactions, and acts as a core member of the Clinical Matrix Team. Hybrid role requiring on-site presence at least two days per week.

AI

• Mississauga, Canada
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director

Serves as the physician on a clinical program team, leading medical monitoring and safety oversight for oncology and hematology studies. Interprets clinical and safety data, contributes to protocol development, and engages with investigators, regulators, and cross-functional matrix teams. May guide other physicians on complex multi-study programs.

AI

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical program teams, leading medical monitoring, safety oversight, and clinical data interpretation across studies. Partners with Senior Scientists and cross-functional matrix teams on protocol development, regulatory interactions, and investigator engagement. May guide other physicians on complex multi-study programs within the clinical strategy set by the Clinical Development Lead.

AI

• Baar Onyx
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical program teams, leading medical monitoring, safety oversight and clinical data interpretation for hematology studies. Partners with a Senior Scientist and cross-functional matrix teams on protocol development, regulatory interactions and investigator engagement, with hybrid working at least two days on-site.

AI

• Stevenage
• Hybrid
• Director

Senior individual-contributor role building a cardiovascular and cardiometabolic translational biology strategy within a respiratory and immunology research unit. Involves evaluating targets, defining human-relevant mechanistic hypotheses, biomarker strategies, multi-omics and reverse translation, plus business development diligence and external academic partnerships across a matrixed organisation.

• USA - Pennsylvania - Upper Providence
• Hybrid
• Director

Senior individual-contributor role building a cardiovascular and cardiometabolic translational biology strategy within a respiratory and immunology research unit. Involves defining human-relevant mechanistic hypotheses, biomarker strategies, target evaluation, and business development diligence, with matrix influence across clinical, genetics, and portfolio teams.

• Stevenage
• Hybrid
• £119,250 – £198,750 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late pre-candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work across small molecules, biologics and antibody drug conjugates, applying AI/ML and quantitative systems pharmacology methods. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

NONMEM · R

• Waltham, United States
• Hybrid
• £188,100 – £313,500 pa
• Director

Leads model-informed drug development for oncology programs, defining and executing model-based strategies from late discovery through lifecycle management. Conducts population PK, exposure-response, simulation-based trial design and dose selection, applying AI/ML, quantitative systems pharmacology and model-based meta-analysis. Presents to governance boards and regulators and works across matrix teams on small molecules, biologics and antibody drug conjugates.

NONMEM · R

• London
• Hybrid
• £119,250 – £198,750 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML and quantitative systems pharmacology methods, and defends results to governance boards and regulators. Sits within Oncology Translational Medicine's Clinical Pharmacology Modelling and Simulation group, working across small molecules, biologics and antibody drug conjugates.

NONMEM · R

• Belgium-Wavre
• Hybrid
• €119,250 – €198,750 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML, quantitative systems pharmacology and model-based meta-analysis to small molecules, biologics and antibody drug conjugates. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

NONMEM · R

• USA - Pennsylvania - Upper Providence
• Hybrid
• US$188,100 – US$313,500 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work across small molecules, biologics and antibody drug conjugates, applying AI/ML and quantitative systems pharmacology methods. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

NONMEM · R

• Durham Blackwell Street
• Hybrid
• US$188,100 – US$313,500 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML and quantitative systems pharmacology methods, and defends results to governance boards and regulators. Sits within a matrixed Clinical Pharmacology Modelling and Simulation group working across small molecules, biologics and antibody drug conjugates.

NONMEM · R

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• £174,750 – £291,250 pa
• Director · manages people

Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, accountable for at least one asset or disease area and its Global Epidemiology Plan. Designs and oversees complex observational studies using claims, EHR and registry data, advises clinical, safety and regulatory matrix teams, and manages external partnerships and scientific dissemination. Also mentors junior epidemiologists and represents the company with regulators and at international conferences.

Electronic Health Records · Claims Data · Registries

• Boston, United States
• Hybrid · 2 days in office
• £174,750 – £320,375 pa
• Director · manages people

Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, designing and overseeing complex studies on disease burden, treatment patterns and safety. Partners across clinical development, safety, regulatory and health outcomes, manages external collaborations, and mentors junior scientists. Hybrid role requiring on-site presence at least two days per week.